Drug Approval | May 03, 2025
Neuland Laboratories completes USFDA inspection at Unit 2
The FDA issued Form 483 with one observation related to building and facility management
The FDA issued Form 483 with one observation related to building and facility management
The inspection concluded with 6 observations and none of them were related to Data Integrity
Raichur site is the group’s largest API facility and part of a wider network of seven sites
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
This will lead to the consolidation and optimization of the company's operations related to the manufacturing of ampoules and vials
The observations issued are neither repeated observations nor related to data integrity
The inspection was successfully completed
Arth by Emcure is a specialized range of supplements designed to address the unique health and wellness needs of women, enabling them to lead healthier and happier lives across all stages
This certification will open new markets for the Kwality Pharma
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection of the facility from September 16 to September 27, 2024
Subscribe To Our Newsletter & Stay Updated
